Tradestie Institutional Equity Comparison Engine
XRN vs SBRA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SBRA Overall Edge
SBRA Captures Institutional Edge (4โ0 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sabra Healthcare REIT, Inc. (SBRA) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, XRN trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus SBRA at 30.4x Forward P/E and 18.4% operating margin (+31.6% YoY). In options structure, XRN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SBRA sits in CONSOLIDATION (17th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
SBRA
XRN N/M vs SBRA 30.4x Fwd P/E
Growth & Margin Winner
SBRA
Op Margin N/A vs 18.4% ยท YoY N/A vs +31.6%
Momentum & Technical Winner
SBRA
1Y -28.2% vs +8.7% ยท 52W Pos 1% vs 52%
Options & Structure Winner
SBRA
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (17th %ile IV)
XRN
US Equity
XRN
Institutional Equity
$25.79
-2.35% 1D
Market Cap
N/A
1M Return
-13.02%
1Y Return
-28.16%
Forward P/E
N/M
Unified AI Score
45.3 / 100
HOLD
Tech 45.0
Fund 53.0
Flow 50.0
Mom 64.0
SBRA
NASDAQ
Sabra Healthcare REIT, Inc.
Real Estate Investment Trusts
$20.27
-0.37% 1D
Market Cap
$5.4B
1M Return
+6.26%
1Y Return
+8.71%
Forward P/E
30.4x
Unified AI Score
57.4 / 100
HOLD
Tech 49.0
Fund 57.0
Flow 57.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
XRN -28.16%
SBRA +8.71%
Spread: +27.4 pp (SBRA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
XRN TTM Op. Margin: N/A
SBRA TTM Op. Margin: 18.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XRN vs SBRA. Trailing 12-month operating profitability (XRN N/A vs SBRA 18.4%) and valuation multiples (XRN N/M vs SBRA 30.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | XRN | SBRA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $5.4B | Larger Scale | SBRA |
| Trailing P/E Ratio Valuation | N/M | 75.7x | Lower Multiple | SBRA |
| Forward P/E Ratio Valuation | N/M | 30.4x | Lower Multiple | SBRA |
| Revenue Growth (YoY) Growth | N/A | +31.6% | Higher Growth | SBRA |
| Operating Margin (TTM) Profitability | N/A | 18.4% | Higher Margin | SBRA |
| Net Profit Margin Profitability | N/A | 7.7% | Higher Margin | SBRA |
| Return on Equity (ROE) Capital Efficiency | N/A | 2.5% | Higher ROE | SBRA |
| 52-Week Range Position Momentum | 1% ($26โ$39) | 52% ($18โ$23) | Stronger Trend | SBRA |
| Beta / 30D Volatility Risk Regime | 0.50ฮฒ ยท 47% Vol | 0.00ฮฒ ยท 30% Vol | Lower Realized Risk | SBRA |
| Unified Institutional Score Composite Signal | 45.3 / 100 (HOLD) | 57.4 / 100 (HOLD) | Higher Composite | SBRA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full XRN vs SBRA Buy Guide
XRN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
SBRA
CONSOLIDATION
80d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
17th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither XRN nor SBRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.